AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON DECEMBER 22, 2005.
REGISTRATION NO. 333-___________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
______________________________________
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
ORBIT INTERNATIONAL CORP.
-------------------------
(Exact Name of Registrant as Specified in Its Charter)
------------------------------------------------------
DELAWARE
(State or Other Jurisdiction of Incorporation or Organization)
--------------------------------------------------------------
11-1826363
(I.R.S. Employer Identification Number)
---------------------------------------
80 Cabot Court
Hauppauge, New York 11788
(631) 435-8300
(Address, Including Zip Code, and Telephone Number, Including Area Code,
of Registrant's Principal Executive Offices)
--------------------------------------------
DENNIS SUNSHINE
PRESIDENT
ORBIT INTERNATIONAL CORP.
80 CABOT COURT
HAUPPAUGE, NEW YORK 11788
(631) 435-8300
(Name, Address, Including Zip Code, and Telephone Number, Including Area Code,
------------------------------------------------------------------------------
of Agent for Service)
---------------------
Copies of All Communications to:
ELLIOT H. LUTZKER, ESQ.
ROBINSON & COLE LLP
885 THIRD AVENUE
NEW YORK, NEW YORK 10022
(212) 451-2906
Approximate Date of Commencement of Proposed Sale to the Public: From time to
time after the effective date of this registration statement.
If the only securities being registered on this form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [_]
If any of the securities being registered on this form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered in connection with dividend or interest
reinvestment plans, check the following box. [x].
-
If this form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective
registration statement for the same offering. [_]
If this form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [_]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
check the following box. [_]
CALCULATION OF REGISTRATION FEE
AMOUNT PROPOSED PROPOSED MAXIMUM
TITLE OF EACH CLASS OF SECURITIES TO BE MAXIMUM OFFERING AGGREGATE OFFERING AMOUNT OF
TO BE REGISTERED REGISTERED (1)(2) PRICE PER SHARE (3) PRICE (3) REGISTRATION FEE
================================= ================= ==================== ==================== =================
Common Stock 206,129 $ 12.14 $ 2,502,406 $ 294.54
================================= ================= ==================== ==================== =================
(1) Pursuant to Rule 416, the shares being registered hereunder include such
indeterminate number of shares of common stock as may be issuable with respect
to the shares being registered hereunder as a result of stock splits, stock
dividends or similar transactions.
(2) The Shares registered hereunder reflects a 25% stock dividend to
Shareholders of record on July 18, 2005. All references to shares and per share
amounts in this prospectus have been retroactively adjusted to reflect the stock
dividend.
(3) Estimated solely for the purpose of calculating the registration fee
pursuant to Rule 457(c) under the Securities Act of 1933 based upon the average
of the high and low prices of the common stock of the Registrant as reported by
the Nasdaq Capital Market on December 21, 2005.
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF THE
SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A),
MAY DETERMINE.
SUBJECT TO COMPLETION, DATED DECEMBER 22, 2005
THE INFORMATION IN THIS PROSPECTUS IS NOT COMPLETE AND MAY BE CHANGED. THESE
SECURITIES MAY NOT BE SOLD UNTIL THE REGISTRATION STATEMENT FILED WITH THE
SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN
OFFER TO SELL THESE SECURITIES AND IT IS NOT SOLICITING AN OFFER TO BUY THESE
SECURITIES IN ANY STATE WHERE THE OFFER OR SALE IS NOT PERMITTED.
PROSPECTUS
ORBIT INTERNATIONAL CORP.
206,129 SHARES OF COMMON STOCK
This prospectus relates to the resale of up to 206,129 shares of our common
stock held of record by the selling shareholders named in the section of this
prospectus entitled "Selling Shareholders". The shares of common stock may be
offered and sold from time to time by the selling shareholders, and any
pledgees, donees, transferees or other successors-in-interest of the shares,
through public or private transactions at fixed prices, at prevailing market
prices at time of sale, at varying prices determined at time of sale or at
negotiated prices. Information regarding the identities of the selling
shareholders, the manner in which they acquired or will acquire their shares and
the manner in which the shares are being offered and sold is provided in the
"Selling Shareholders" and "Plan of Distribution" sections of this prospectus.
We will not receive any of the proceeds from the sale of the shares. We
have agreed to bear all of the expenses in connection with the registration and
sale of the shares, except for sales commissions.
Our common stock is quoted on the Nasdaq Capital Market under the symbol
"ORBT". The last reported sale price of our common stock on the Nasdaq Capital
Market on December 21, 2005, was $12.14 per share.
Our principal executive offices are located at 80 Cabot Court, Hauppauge,
New York 11788 and our telephone number is (631) 435-8300.
INVESTING IN OUR COMMON STOCK INVOLVES RISKS. SEE "RISK FACTORS" BEGINNING
ON PAGE 6.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE
ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
The date of this prospectus is [____________], 2005.
1
YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS PROSPECTUS. WE
HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH DIFFERENT INFORMATION. WE ARE NOT
MAKING AN OFFER OF THESE SECURITIES IN ANY STATE WHERE THE OFFER IS NOT
PERMITTED. YOU SHOULD NOT ASSUME THAT THE INFORMATION CONTAINED IN THIS
PROSPECTUS IS ACCURATE AS OF ANY DATE OTHER THAN THE DATE ON THE COVER PAGE OF
THIS PROSPECTUS.
________________
TABLE OF CONTENTS
PAGE
- ---------------------------------------
FORWARD-LOOKING STATEMENTS 3
ABOUT THIS PROSPECTUS 4
SUMMARY 5
RISK FACTORS 3
USE OF PROCEEDS 7
SELLING SHAREHOLDERS 7
PLAN OF DISTRIBUTION 8
LEGAL MATTERS 10
EXPERTS 10
WHERE YOU CAN FIND MORE INFORMATION 10
INCORPORATION BY REFERENCE 11
-2-
FORWARD-LOOKING STATEMENTS
This prospectus, including the information that we incorporate by
reference, contains various forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended (the "Securities Act"),
and Section 21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"). These statements relate to future events or our future
financial performance and involve known and unknown risks, uncertainties and
other factors that may cause our actual results, levels of activity, performance
or achievements to differ materially from any future results, levels of
activity, performance or achievements expressed or implied by these
forward-looking statements. In some cases, you can identify forward-looking
statements by terminology such as "anticipates," "believes," "continue"
"estimates," "expects," "intends," "may," "plans," "potential," "predicts,"
"should," "will," or the negative of these terms or other comparable
terminology. These forward-looking statements may also use different phrases.
Discussions containing these forward-looking statements may be found, among
other places, in sections entitled "Description of Business" and "Management's
Discussion and Analysis of Financial Condition and Results of Operations"
incorporated by reference from our most recent annual report on Form 10-KSB and
in our most recent quarterly report on Form 10-QSB subsequent to the filing of
our most recent annual report on Form 10-KSB with the Securities and Exchange
Commission, or SEC, as well as any amendments thereto reflected in subsequent
filings with the SEC. We may not actually achieve the plans, intentions or
expectations disclosed in our forward-looking statements and you should not
place undue reliance on our forward-looking statements. Actual results or events
could differ materially from the plans, intentions and expectations disclosed in
the forward-looking statements we make. Forward-looking statements include, but
are not limited to, statements about:
- - the development and commercialization for our technology and products;
- - our estimates regarding anticipated capital requirements;
- - our expectation of customer orders for our products;
- - the timing and availability of our products;
- - our business strategy; and
- - general economic conditions in the electronics industry and our target
markets.
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results, performance
or achievements to differ materially from any future results, performance or
achievements expressed or implied by such forward-looking statements. These
risks include those risks discussed under the heading "Risk Factors" and
elsewhere in this prospectus. Because the factors referred to above could cause
actual results or outcomes to differ materially from those expressed in any
forward-looking statements made by us or on our behalf, you should not place
undue reliance on any forward-looking statements. New factors emerge from time
to time, and it is not possible for us to predict which factors will arise. In
addition, we cannot assess the impact of each factor on our business or the
extent to which any factor, or combination of factors, may cause actual results
to differ materially from those contained in any forward-looking statements.
Further, any forward-looking statement speaks only as of the date on which it is
made, and, except as required by law, we undertake no obligation to publicly
revise our forward-looking statements to reflect events or circumstances that
arise after the date of this prospectus or the date of documents incorporated by
reference in this prospectus that include forward-looking statements.
ABOUT THIS PROSPECTUS
This prospectus is part of a registration statement that we filed with the
SEC, using a continuous offering process. Under this continuous offering
process, the selling shareholders may, from time to time, sell the securities
described in this prospectus in one or more offerings. This prospectus
provides you with a general description of the securities that may be offered by
the selling shareholders. Each time a selling shareholder sells securities,
the selling shareholder is required to provide you with this prospectus and, in
certain cases, a prospectus supplement containing more specific information
about the selling shareholder and the terms of the securities being offered.
That prospectus supplement may also add, update or change information in this
prospectus. If there is any inconsistency between the information in this
prospectus and any prospectus supplement, you should rely on the information in
that prospectus supplement. This prospectus, together with any applicable
prospectus supplements, includes all material information relating to this
offering. You should carefully read both this prospectus and any prospectus
supplement together with the additional information described in the section
entitled "Where You Can Find More Information."
SUMMARY
This summary highlights information contained elsewhere in this prospectus
and in the documents incorporated by reference herein and does not contain all
of the information you should consider in making your investment decision. You
should read this summary together with the more detailed information, including
our business information, financial statements and the related notes,
incorporated by reference in this prospectus, as well as the information set
forth in any prospectus supplement. You should carefully consider, among other
things, the matters discussed in the section entitled "Risk Factors."
ORBIT INTERNATIONAL CORP.
Orbit was incorporated under the laws of the State of New York on April 4,
1957 as Orbit Instrument Corp. In December 1986, our state of incorporation was
changed from New York to Delaware and in July 1991, our name was changed to
Orbit International Corp. We conduct our operations through our wholly-owned
subsidiaries, Orbit Instrument of California, Inc., Behlman Electronics, Inc.
("Behlman"), Tulip Development Laboratory, Inc., or TDL and TDL Manufacturing,
Inc., or TDLM. Through our Orbit Instrument Division, we are engaged in the
design, manufacture and sale of customized electronic components and subsystems.
Behlman is engaged in the design and manufacture of distortion free commercial
power units, power conversion devices and electronic devices for measurement and
display.
On April 4, 2005, we acquired all of the issued and outstanding
capital stock of TDL and its affiliated manufacturing company TDLM
(collectively, "Tulip"), pursuant to a certain Stock Purchase Agreement dated
as of December 13, 2004, by and among us, as Buyer, and Tulip, TDLM and their
respective shareholders (the selling shareholders herein), as the Sellers. The
total transaction value was $8,500,000 consisting of $5,000,000 in cash, a
$2,000,000 promissory note to the sellers and $1,500,000 in value of our common
stock. Headquartered in Quakertown, Pennsylvania, TDL is a leading designer and
engineering provider of computer peripheral products including custom integrated
solutions for keyboards, illuminated data entry devices and displays. TDLM
provides both defense contractors and commercial customers with high volume
production to support membrane control panels, military vetronic and avionic
display program requirements. In connection with the acquisition of Tulip, we
issued an aggregate of 206,129 shares of our common stock to the selling
shareholders. We also entered into a registration rights agreement with the
selling shareholders pursuant to such acquisition, whereby we agreed to register
the shares of our common stock issued to the selling shareholders within 270
days following the closing date of the acquisition. In addition, we granted the
selling shareholders demand (subject to our failure to timely file a
registration statement) and piggyback registration rights pursuant to the
registration rights agreement.
Our executive offices are located at 80 Cabot Court, Hauppauge, New York
11788. Our telephone number is (631) 435-8300. We maintain a web site at the
following Internet address: www.orbitintl.com. The information on our web site
is not part of this prospectus.
Unless the context otherwise requires, references in this prospectus to "Orbit,"
"we," "us" and "our" refer to Orbit International Corp.
THE OFFERING
Common Stock offered 206,129 shares.
Common Stock outstanding 4,574,906 shares.(1)
Risk factors
Investment in our common stock involves a high degree of
risk. You should carefully consider the risk factors described under the
section entitled "Risk Factors", as well as any other information in this
prospectus and any prospectus supplement before purchasing any of our
securities. Each of these risk factors could adversely affect our business,
operating results and financial condition, as well as adversely affect the value
of an investment in our securities.
Use of proceeds
The proceeds from the sale of the shares of our common
stock being offered by the selling shareholders pursuant to this prospectus, net
of any broker's fee or commissions, will belong to the selling shareholders. We
will not receive any of the proceeds from the sale of these shares. See section
entitled "Use of Proceeds".
Plan of Distribution
The shares of common stock may be
offered and sold from time to time by selling shareholders, and any pledgees,
donees, transferees or other successors-in-interest of the shares, through
public or private transactions at fixed prices, at prevailing market prices at
time of sale, at varying prices determined at time of sale or at negotiated
prices. See section entitled "Plan of Distribution".
Nasdaq Capital Market symbol ORBT.
(1) The above outstanding share information is based upon shares of our
common stock outstanding as of December 19, 2005. The above outstanding share
information excludes 615,547 shares of our common stock issuable upon the
exercise of options outstanding at December 19, 2005; and an aggregate of 7,139
shares of our common stock available for future issuance under our stock option
plans.
RISK FACTORS
INVESTING IN OUR SECURITIES INVOLVES RISKS. BEFORE INVESTING IN OUR
SECURITIES, YOU SHOULD CAREFULLY CONSIDER THE FOLLOWING RISK FACTORS AS WELL AS
THE OTHER INFORMATION INCLUDED AND INCORPORATED BY REFERENCE IN THIS PROSPECTUS.
IF ANY OF THE FOLLOWING RISKS ACTUALLY OCCUR, OUR BUSINESS, FINANCIAL CONDITION,
OR RESULTS OF OPERATIONS AND COULD BE MATERIALLY AND ADVERSELY AFFECTED. IN SUCH
CASES, THE TRADING PRICE OF OUR SECURITIES COULD DECLINE, AND YOU MAY LOSE ALL
OR PART OF YOUR INVESTMENT.
WE ARE DEPENDENT UPON THE CONTINUANCE OF MILITARY SPENDING.
A significant amount of all the products we manufacture are used in
military applications. The attacks of September 11, 2001 and subsequent world
events have led the U.S. Government to increase the level of military spending
necessary for domestic and overseas security. We are dependent upon military
spending, as a source of revenues and income. Accordingly, any substantial
future reductions in overall military spending by the U.S. Government could have
a material adverse effect on our sales and earnings.
WE ARE DEPENDENT ON CERTAIN OF OUR CUSTOMERS AND WE DO NOT HAVE ANY LONG TERM
CONTRACTS WITH THESE CUSTOMERS.
A unit of BAE SYSTEMS, various agencies of the U.S. Government and
Raytheon Company accounted for approximately 25%, 20%, and 11%, respectively, of
our consolidated net sales for the year ended December 31, 2004. A unit of BAE
SYSTEMS, various agencies of the U.S. Government, Raytheon Company and Lockheed
Martin Corp. accounted for approximately 41%, 18%, 16% and 11%, respectively, of
the net sales of our Electronics Segment for the year ended December 31, 2004.
Various agencies of the U.S. Government accounted for approximately 23% of the
net sales of our Power Units Segment for the year ended December 31, 2004. We
do not have any significant long-term contracts with any of the above-mentioned
customers. The loss of any of these customers would have a material adverse
effect on our net sales and earnings. Due to major consolidations in the
defense industry, it has become more difficult to avoid dependence on certain
customers for revenue and income.
WE COULD HAVE DIFFICULTIES IN PROCURING CONTRACTS BECAUSE OF A REDUCTION IN THE
LEVEL OF INDUSTRY-WIDE FUNDING AND PRICING PRESSURES.
We continue to pursue many business opportunities, including programs in
which we have previously participated but, due to industry-wide funding and
pricing pressures, we could encounter delays in the awards of these contracts.
We continue to seek new contracts which require incurring up-front design,
engineering, prototype and pre-production costs. While we are attempting to
negotiate contract awards for reimbursement of product development, there is no
assurance that sufficient monies will be set aside by our customers, including
the U.S. Government, for such effort. In addition, even if the U.S. Government
agrees to reimburse development costs, there is still a significant risk of cost
overrun which may not be reimbursable. Furthermore, once we have completed the
design and pre-production stage, there is no assurance that funding will be
provided for future production.
A significant amount of our contracts are subject to termination at the
convenience of the U.S. Government. Orders under U.S. Government prime
contracts or subcontracts are customarily subject to termination at the
convenience of the U.S. Government, in which event the contractor is normally
entitled to reimbursement for allowable costs and a reasonable allowance for
profits, unless the termination of a contract was due to a default on the part
of the contractor.
MANY OF OUR COMPETITORS POSSESS FINANCIAL RESOURCES SIGNIFICANTLY GREATER THAN
US AND ACCORDINGLY, COULD INITIATE AND SUPPORT PROLONGED PRICE COMPETITION TO
GAIN MARKET SHARE.
Many of our competitors are well established, have reputations for success
in the development and sale of their products and services and have
significantly greater financial, marketing, distribution, personnel and other
resources than us, thereby permitting them to implement extensive advertising
and promotional campaigns, both in general and in response to efforts by
additional competitors to enter into new markets and introduce new products and
services.
The electronics industry is characterized by frequent introduction of new
products and services, and is subject to changing consumer preferences and
industry trends, which may adversely affect our ability to plan for future
design, development and marketing of our products and services. The markets for
electronic products, components and related services are also characterized by
rapidly changing technology and evolving industry standards, often resulting in
product obsolescence or short product life cycles. We are constantly required
to expend more sums for research and development of new technologies and
products.
We believe that our electronics segment's competitive position within the
electronics industry is predicated upon our manufacturing techniques, our
ability to design and manufacture products which will meet the specific needs of
our customers and our long-standing relationships with our major customers.
There are numerous companies, many of which have greater resources than us,
capable of producing substantially all of our products.
Competition in the markets for the power unit segment's commercial and military
products depends on such factors as price, product reliability and performance,
engineering and production. In particular, due primarily to budgetary
restraints and program cutbacks, competition has been increasingly severe and
price has generally become the major overriding factor in contract and
subcontract awards. There can be no assurance of our ability to compete
effectively.
WE MAY NOT BE SUCCESSFUL IN OUR EXPANSION EFFORTS.
We have a strategy to expand our operations through strategic acquisitions.
Through the past several years we reviewed various potential acquisitions and
believe there are numerous opportunities presently available. In April 2005, we
completed the acquisition of Tulip. While there can be no assurance we will
obtain the necessary financing to complete additional acquisitions, even if we
do, there can be no assurance that we will have sufficient income from
operations of such acquired companies to satisfy the interest payments, in which
case, we will be required to pay them out of Orbit's operations which may then
be adversely affected. Furthermore, there can be no assurance we will be able
to successfully complete the integration of any future acquired business nor
that such acquisition will be profitable and enable us to grow our business.
WE ARE DEPENDENT UPON OUR SENIOR EXECUTIVE OFFICERS AND KEY PERSONNEL FOR THE
OPERATION OF OUR BUSINESS.
We are dependent for the operation of our business on the experience,
technology, knowledge, abilities and continued services of our officers, Dennis
Sunshine, President and Chief Executive Officer, Bruce Reissman, Executive Vice
President and Chief Operating Officer and Mitchell Binder, Vice
President-Finance and Chief Financial Officer and Richard Hetherington,
President and Chief Operating Officer of Tulip and TDLM. The loss of services
of any of such persons would be expected to have a material adverse effect upon
our business and/or our prospects. Our future success is dependent upon, among
other things, the successful recruitment and retention of key personnel
including executive officers, for sales, marketing, finance and operations. We
face significant competition for skilled and technical talent. No assurance can
be made that we will be successful in attracting and retaining such personnel.
If we are unable to retain existing key employees or hire new employees upon
acceptable terms when necessary, our business could potentially be adversely
affected.
WE MAY HAVE DIFFICULTY PROCURING CERTAIN RAW MATERIALS ON TERMS SATISFACTORY TO
US.
We use multiple sources for our procurement of raw materials and we are not
dependent on any suppliers for such procurement. Occasionally, however, in the
production of certain military units, we will be faced with procuring certain
components that are either obsolete or difficult to procure. Although we
believe that with our access to worldwide brokers using the Internet we can
obtain the necessary components, there can be no assurance that such components
will be available, and even if so, at reasonable prices.
AS A DELAWARE CORPORATION WE ARE PROHIBITED FROM ENGAGING IN BUSINESS
COMBINATIONS WHICH COULD POTENTIALLY LIMIT THE PRICE INVESTORS WILL BE WILLING
TO PAY FOR OUR SECURITIES.
We are subject to the provisions of Section 203 of the General Corporation
Law of Delaware. In general, Section 203 provides, with certain exceptions, that
a Delaware corporation may not engage in any of a broad range of "business
combinations" with an "interested stockholder" for a period of three years from
the date that such person became an interested stockholder unless: (i) the
transaction resulting in a person's becoming an interested stockholder, or the
business combination is approved by the board of directors of the corporation
before the person becomes an interested stockholder; (ii) the interested
stockholder acquires at least 85% or more of the outstanding voting stock of the
corporation (excluding shares held by persons who are both officers and
directors of the corporation, and shares held by certain employee stock
ownership plans); or (iii) the business combination is approved by the
corporations' board of directors and by holders of at least 66 2/3% of the
corporation's outstanding voting stock at an annual or special meeting,
excluding shares owned by the interested stockholder. A "business combination"
includes mergers, asset sales, and other transactions resulting in a financial
benefit to the interested stockholder. Subject to certain exceptions, an
"interested stockholder" is a person who, together with affiliates and
associates, owns, or within the previous three years did own, 15% or more of the
corporation's voting stock. This provision of the Delaware law could delay and
make more difficult a business combination even if the business combination
could be beneficial, in the short term, to the interests of the stockholders.
This provision of the Delaware law could also limit the price certain investors
might be willing to pay in the future for our securities.
THE MARKET FOR OUR COMMON STOCK IS HIGHLY VOLATILE.
The trading price of our common stock could be subject to wide fluctuations
in response to quarterly variations in operating and financial results,
announcements of technological innovations or new products by the Issuer or its
competitors, changes in our prices or our competitors' products and services, as
well as other events or factors. Statements or changes in opinion, earnings
estimates made by brokerage firms or industry analysts relating to the market in
which we do business or relating to Orbit could result in an immediate and
adverse effect on the market price of our common stock. Statements by financial
or industry analysts may be expected to contribute to volatility in the market
price of our common stock. In addition, the stock market has from time to time
experienced extreme price and volume fluctuations which have particularly
affected the market price for the securities of many companies, similar to that
of Orbit and which often have been unrelated to the operating performance of
these particular companies. These broad market fluctuations may adversely
affect the market price of our common stock.
USE OF PROCEEDS
The proceeds from the sale of the shares of our common stock being offered
by the selling shareholders pursuant to this prospectus, net of any broker's fee
or commissions, will belong to the selling shareholders. Accordingly, we will
not receive any of the proceeds from the sale of these shares.
SELLING SHAREHOLDERS
The shares of our common stock that may be offered with this prospectus
will be offered by the selling shareholders, which include their transferees,
pledgees or donees or their successors. The following table sets forth certain
information concerning the shares of our common stock beneficially owned by each
selling shareholder that may be offered from time to time with this prospectus.
We have prepared the table below based on information given to us by the selling
shareholders prior to the date of this prospectus. However, any, all or none of
the shares of our common stock listed below may be offered for sale with this
prospectus by the selling shareholders from time to time. Accordingly, no
estimate can be given as to the amount of shares of our common stock that will
be held by the selling shareholders upon consummation of any sales.
Information about the selling shareholders may change over time. Any changed
information will be set forth in prospectus supplements or post-effective
amendments. From time to time, however, the shares of our common stock may be
owned by persons not named in the table below and of whom we are unaware.
NUMBER OF NUMBER OF NUMBER OF
COMMON COMMON COMMON PERCENTAGE
SHARES SHARES BEING SHARES BENEFICIALLY
BENEFICIALLY OFFERED FOR BENEFICIALLY OWNED AFTER
OWNED BEFORE SALE IN THIS OWNED AFTER THIS
NAME AND ADDRESS THIS OFFERING OFFERING THIS OFFERING(1)OFFERING
Richard A. Hetherington 43,802 43,802 -0- -
------ ------ --- -
Joanne Hetherington 78,845 78,845 -0- -
------ ------ --- -
Larry M. Bateman 23,190 23,190 -0- -
------ ------ --- -
Stephen Hill 60,292 60,292 -0- -
------ ------ --- -
______________
_
* Less than 1%
(1) Assumes all shares of our common listed in the above table will be sold by
the selling shareholders.
Richard A. Hetherington is President and Chief Operating Officer of TDL and
TDLM, our wholly-owned subsidiaries. None of the other selling shareholders
has, or within the past three years has had, any position, office or other
material relationship with us or any of our predecessors or affiliates.
Only selling shareholders identified above who beneficially own the
securities set forth opposite each such selling shareholder's name in the
foregoing table, on the effective date of the registration statement of which
this prospectus forms a part, may sell such securities under this prospectus.
Prior to any use of this prospectus in connection with an offering of our common
stock by any holder not identified above, this prospectus will be supplemented
or amended to set forth the name and other information about the selling
shareholder intending to sell such common stock. The prospectus supplement or
post-effective amendment will also disclose whether any selling shareholder
selling in connection with such prospectus supplement or post-effective
amendment has held any position or office with, been employed by or otherwise
has had a material relationship with, us or any of our affiliates during the
three years prior to the date of the prospectus supplement or post-effective
amendment if such information has not been disclosed in this prospectus.
PLAN OF DISTRIBUTION
We are registering 206,129 shares of our common stock under this prospectus
on behalf of the selling shareholders. To our knowledge, none of the selling
shareholders has not entered into any agreement, arrangement or understanding
with any particular broker or market maker with respect to the shares of common
stock offered hereby, nor do we know the identity of the brokers or market
makers that will participate in the sale of the shares.
Any selling shareholder may decide not to sell any of his/her shares. The
selling shareholders may from time to time offer some or all of the shares of
common stock through brokers, dealers or agents who may receive compensation in
the form of discounts, concessions or commissions from the selling shareholders
and/or the purchasers of the shares of common stock for whom they may act as
agent. In effecting sales, broker-dealers that are engaged by the selling
shareholders may arrange for other broker-dealers to participate. Any brokers,
dealers or agents who participate in the distribution of the shares of common
stock may be deemed to be "underwriters," and any profits on the sale of the
shares of common stock by them and any discounts, commissions or concessions
received by any such brokers, dealers or agents may be deemed to be underwriting
discounts and commissions under the Securities Act. To the extent any selling
shareholders may be deemed to be an underwriter, such selling shareholder will
be subject to the prospectus delivery requirements of the Securities Act and may
be subject to certain statutory liabilities of, including, but not limited to,
Sections 11, 12 and 17 of the Securities Act and Rule 10b-5 under the Exchange
Act.
The selling shareholders will act independently of us in making decisions
with respect to the timing, manner and size of each sale. Such sales may be made
in private transactions, over the Nasdaq Capital Market, on the over-the-counter
market, otherwise, or in a combination of such methods of sale, at fixed prices,
at then prevailing market prices, at prices related to prevailing market prices
or at negotiated prices. The shares of common stock may be sold according to one
or more of the following methods:
- a block trade in which the broker or dealer so engaged will
attempt to sell the shares of common stock as agent but may position and resell
a portion of the block as principal to facilitate the transaction;
- purchases by a broker or dealer as principal and resale by such
broker or dealer for its account pursuant to this prospectus;
- an over-the-counter distribution in accordance with the rules of
the Nasdaq;
- ordinary brokerage transactions and transactions in which the
broker solicits purchasers;
- privately negotiated transactions;
- a combination of such methods of sale; and
- any other method permitted pursuant to applicable law.
Any shares covered by this prospectus which qualify for sale pursuant to
Rule 144 of the Securities Act may be sold under Rule 144 rather than pursuant
to this prospectus.
The selling shareholders may effect such transactions by selling the shares
to or through broker-dealers, and such broker-dealers may receive compensation
in the form of underwriting discounts, concessions, commissions, or fees from
the selling shareholders and/or purchasers of the shares for whom such
broker-dealers may act as agent or to whom they sell as principal, or both
(which compensation to a particular broker-dealer might be in excess of
customary commissions).
The selling shareholders may enter into hedging transactions with
broker-dealers in connection with distributions of the shares or otherwise. In
these transactions, broker-dealers may engage in short sales of the shares in
the course of hedging the positions they assume with selling shareholders. The
selling shareholders may also sell shares short and redeliver the shares to
close out such short positions. The selling shareholders may enter into options
or other transactions with broker-dealers that require the delivery to the
broker-dealer of the shares. The broker-dealer may then resell or otherwise
transfer such shares pursuant to this prospectus. The selling shareholders also
may loan or pledge the shares to a broker-dealer. The broker-dealer may sell the
shares so loaned, or upon default, the broker-dealer may sell the pledged shares
pursuant to this prospectus.
If we are notified by any selling shareholder that any arrangement has been
entered into with a broker-dealer for the sale of shares offered pursuant to
this prospectus, we will, to the extent required under the Securities Act, file
an amendment or supplement to this prospectus, disclosing:
- the name of any such broker-dealers;
- the number of shares involved;
- the price at which such shares are to be sold;
- the commission paid or discounts or concessions allowed to such
broker-dealers, where applicable;
- that such broker-dealers did not conduct any investigation to
verify the information set out or incorporated by reference in this prospectus,
as supplemented; and
- other facts material to the transaction.
Underwriters and purchasers that are deemed underwriters under the
Securities Act may engage in transactions that stabilize, maintain or otherwise
affect the price of the securities, including the entry of stabilizing bids or
syndicate covering transactions or the imposition of penalty bids. Any persons
participating in the sale or distribution of the shares will be subject to the
applicable provisions of the Exchange Act and the rules and regulations
thereunder including, without limitation, Regulation M. These provisions may
restrict certain activities of, and limit the timing of, purchases by the
selling shareholders or other persons or entities. Furthermore, under Regulation
M, persons engaged in a distribution of securities are prohibited from
simultaneously engaging in market making and certain other activities with
respect to such securities for a specified period of time prior to the
commencement of such distributions, subject to special exceptions or exemptions.
Regulation M may restrict the ability of any person engaged in the distribution
of the securities to engage in market-making and certain other activities with
respect to those securities. In addition, the anti-manipulation rules under the
Exchange Act may apply to sales of the securities in the market. All of these
limitations may affect the marketability of the shares and the ability of any
person to engage in market-making activities with respect to the securities.
We have agreed to pay the expenses of registering the shares of common
stock under the Securities Act, including registration and filing fees, printing
expenses, administrative expenses and certain legal and accounting fees. The
selling shareholders will bear all discounts, commissions or other amounts
payable to underwriters, dealers or agents, as well as transfer taxes and
certain other expenses associated with the sale of securities.
Under the terms of the registration rights agreement, we and the selling
shareholders have agreed to indemnify each other against certain liabilities in
connection with the offering of the shares of common stock offered hereby,
including liabilities arising under the Securities Act or, if such indemnity is
unavailable, to contribute toward amounts required to be paid in respect of such
liabilities.
At any time a particular offer of the shares of common stock is made, a
revised prospectus or prospectus supplement, if required, will be distributed.
Such prospectus supplement or post-effective amendment will be filed with the
SEC, to reflect the disclosure of required additional information with respect
to the distribution of the shares of common stock.
LEGAL MATTERS
The validity of the securities offered hereby has been passed upon for us
by Robinson & Cole LLP, New York, New York.
EXPERTS
The consolidated financial statements of Orbit and Subsidiaries as of
December 31, 2004 and 2003, and for the related consolidated statements of
operations, stockholders' equity and cash flows for the years then ended,
incorporated by reference in this prospectus and in the registration statement
of which this prospectus is a part, from our Annual Report on Form 10-KSB for
the year ended December 31, 2004, have been audited by Goldstein Golub Kessler
LLP, independent registered public accounting firm, as stated in their report,
and have been so incorporated in reliance upon the report given on their
authority as experts in accounting and auditing.
WHERE YOU CAN FIND MORE INFORMATION
We have filed with the Securities and Exchange Commission a
registration statement on Form S-3 under the Securities Act with respect to the
shares of our common stock offered hereby by the selling shareholders. This
prospectus, which constitutes a part of the registration statement, does not
contain all of the information set forth in the registration statement or the
exhibits and schedules filed therewith. For further information about us and our
common stock offered hereby, reference is made to the registration statement and
the exhibits and schedules filed therewith. Statements contained in this
prospectus regarding the contents of any contract or any other document that is
filed as an exhibit to the registration statement are not necessarily complete,
and each such statement is qualified in all respects by reference to the full
text of such contract or other document filed as an exhibit to the registration
statement. A copy of the registration statement and the exhibits and schedules
filed therewith may be inspected without charge at the public reference room
maintained by the SEC, located at 100 F Street, N.E., Washington, D.C. 20549,
and copies of all or any part of the registration statement may be obtained from
such offices upon the payment of the fees prescribed by the SEC. Please call the
SEC at 1-800-SEC-0330 for further information about the public reference room.
The SEC also maintains an Internet web site that contains reports, proxy and
information statements and other information regarding registrants that file
electronically with the SEC. The address of the site is http://www.sec.gov. We
also maintain a web site at the following Internet address: www.orbitintl.com.
The information on our web site is not part of this prospectus.
We are subject to the informational requirements of the Exchange Act and,
therefore, we file annual, quarterly and current reports, proxy statements and
other information with the SEC. Such periodic reports, proxy statements and
other information are available for inspection and copying at the public
reference room and web site of the SEC referred to above. Our common stock is
quoted on the Nasdaq Capital Market, and you may also inspect and copy our SEC
filings at the offices of the NASD, Inc. located at 1735 K Street, N.W.,
Washington, D.C. 20549.
You should rely only on the information provided in this prospectus and the
registration statement. We have not authorized anyone else to provide you with
different information. These securities are not being offered in any state
where the offer is not permitted. You should assume that the information in
this prospectus is accurate only as of the dates of those documents. Our
business, financial condition, results of operations and prospects may have
changed since those dates.
MATERIAL CHANGES
There have been no material changes in the Company's affairs since December
31, 2004, which have not been described in a report on Form 10-QSB or Form 8-K.
INCORPORATION BY REFERENCE
The Securities and Exchange Commission allows us to "incorporate by
reference" information that we file with it, which means that we can disclose
important information to you by referring you to those documents. The
information incorporated by reference is an important part of this prospectus.
Information in this prospectus supersedes information incorporated by reference
that we filed with the SEC prior to the date of this prospectus, while
information that we file later with the SEC will automatically update and
supersede this information. We incorporate by reference into this registration
statement and prospectus the documents listed below, and any future filings we
will make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the
Securities Exchange Act of 1934:
1. Our Annual Report on Form 10-KSB for the fiscal year ended December 31,
2004;
2. Our Proxy for our shareholders' meeting on June 24, 2005, filed on April
29, 2005;
3. Our Quarterly Reports on Form 10-QSB for the quarters ended March 31,
2005, June 30, 2005 and September 30, 2005;
4. Our Current Reports on Form 8-K filed April 8, 2005, May 6, 2005, June
17, 2005 (Form 8-K/A), August 5, 2005, September 16, 2005 and November 9, 2005;
and
5. The description of our common stock set forth in our registration
statement on Form 10, filed with the SEC on August 28, 1969, including any
amendments or reports filed for the purposes of updating this description.
We will furnish without charge to you, on written or oral request, a copy
of any or all of the documents incorporated by reference, including exhibits to
these documents. You should direct any requests for documents to Orbit
International Corp., Attention: Corporate Secretary, 80 Cabot Court, Hauppauge,
New York 11788, telephone: (631) 435-8300.
_______________________________________________________________________________
_______________________________________________________________________________
____________
ORBIT INTERNATIONAL CORP.
206,129 Shares of Common Stock
______________
PROSPECTUS
[______________], 2005
_______________________________________________________________________________
_______________________________________________________________________________
____________
II-4
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
ITEM 14. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.
The following table sets forth all expenses payable by us in connection with the
offering of the securities being registered. All such expenses are being borne
by us.
SEC Registration Fee $ 294.54
Accounting Fees and Expenses* $ 2,000.00
Legal Fees and Expenses* $ 10,000.00
Miscellaneous Expenses* $ 705.46
Total* $ 13,000.00
-----------
* Estimated.
ITEM 15. INDEMNIFICATION OF DIRECTORS AND OFFICERS
Delaware General Corporation Law (the "DGCL"), Section 102(b)(7),
enables a corporation in its original certificate of incorporation, or an
amendment thereto validly approved by stockholders, to eliminate or limit
personal liability of a director to the corporation or its stockholders for
monetary damages for breach of fiduciary duty as a director, provided that such
provision shall not eliminate or limit the liability of a director: (1) for any
breach of the director's duty of loyalty to the corporation or its stockholders;
(ii) for acts or omissions not in good faith or which involve intentional
misconduct or
a knowing violation of law; (iii) for any unlawful payment of dividends or
stock purchase or redemption under section 174 of DGCL; or (iv) for any
transaction from which the director derived an improper personal benefit.
Section (A) of Article 11 of our Certificate of Incorporation, as amended,
eliminates the liability of directors to the extent permitted by Section 102(b)
(7) of the DGCL.
In addition, Section 145 of the DGCL which provides that a corporation
may indemnify any person who was or is a party or is threatened to be made a
party to any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative (other than an action
by or in right of the corporation) by reason of the fact that the person is or
was a director, officer, employee or agent of the corporation, or is or was
serving at the request of the corporation as a director, officer, employee or
agent of another corporation or other enterprise, against expenses (including
attorneys' fees), judgments, fines and amounts paid in settlement in
actually and reasonably incurred by the person in connection with such
action, suit or proceeding, if the person acted in good faith and in a manner
the person reasonably believed to be in or not opposed to the best interests of
the corporation, and, with respect to any criminal action or proceeding, had no
reasonable cause to believe his conduct was unlawful. A similar standard is
applicable in the case of derivative actions, except that
indemnification only extends to expenses (including attorneys' fees)
incurred in connection with defense or settlement of such action, and no
indemnification shall be made in respect of any claim, issue or matter as to
which such person shall have been adjudged to be liable to the corporation
unless and only to the extent that the court determines that such person is
entitled to indemnity despite the adjudication of liability. Section 145
further acknowledges that the indemnification provisions provided therein are
not exclusive of any other rights to which those seeking indemnification may be
entitled under a corporation's by-laws, agreement, vote of stockholders or
disinterested directors or otherwise. Article 11 of our Certificate of
Incorporation provides for such indemnification of our directors and officers as
permitted by Delaware law.
In connection with the indemnification of our directors and officers,
Article 11 of our Certificate of Incorporation provides in pertinent part as
follows:
(A) No person serving as director of the corporation shall be liable
to the corporation or its shareholders for monetary damages for breach of
fiduciary duty as a director, provided that this provision shall not eliminate
nor limit the liability of a director (i) for any breach of the director's duty
of loyalty to the corporation or its shareholders, (ii) for acts or omissions
not in good faith or which involve intentional misconduct or a knowing violation
of law, (iii) under Section 174 of the Delaware Corporation Law, or (iv) for any
transaction from which the director derived an improper personal benefit.
(B)(i) Each person who was or is made a party or is threatened to be
made a party to or is involved in any action, suit or proceeding, whether
civil, criminal, administrative or investigative (hereinafter a "proceeding")
other than an action by or in the right of the Corporation, by reason of the
fact that he or she, or a person of whom he or she is the legal representative,
is or was a director, officer, employee or agent of the corporation or of
another corporation or a partnership, joint venture, trust or other enterprise
at the request of the corporation, including service with respect to employee
benefit plans, including a proceeding the basis of which is alleged action
outside the scope of authority while serving as a director, officer, employee
or agent, shall be indemnified and held harmless by the corporation to the
fullest extent authorized by the Delaware General Corporation law, as the
same exists or may hereafter be amended (but, in the case of any such amendment,
only to the extent that such amendment permits the corporation to provide
broader indemnification rights than said law permitted the corporation to
provide prior to such amendment), against all expense, liability and loss
(including attorneys' fees, judgments, fines, ERISA exercise taxes or
penalties and amounts paid in settlement) reasonably incurred or suffered
by such person in connection therewith and such indemnification shall
continue as to a person who has ceased to be a director, officer, employee or
agent and shall inure to the benefit of his or her heirs, executors and
administrators; provided, however, that except as provided in subparagraph
(ii) hereof, the corporation shall indemnify any such person seeking
indemnification in connection with a proceeding (or part thereof) initiated by
such persons only if such proceeding (or part thereof) was authorized by the
Board of Directors of the Corporation. The right to indemnification
hereunder shall be a contract right and shall include the right to be paid by
the corporation the expenses incurred in defending any such proceeding in
advance of its final disposition; provided, however, that, if the Delaware
General Corporation law requires, the payment of such expenses incurred by a
director or officer in his or her capacity as a director or officer (and not
in any other capacity in which service was or is rendered by such person while
a director or officer, including without limitation, service to an employee
benefit plan) in advance of the final disposition of a proceeding, shall be
made upon delivery to the corporation of an undertaking by or on behalf of such
director or officer to repay all amounts so advanced if it shall ultimately be
determined that such director or officer is not entitled to be indemnified
hereunder or otherwise. The corporation may by action of its Board of
Directors, provide indemnification to employees and agents of the corporation
with the same scope and effect as the foregoing indemnification of directors and
officers.
(ii) If a claim under paragraph (B)(i) above is not paid in full by
the corporation within thirty days after a written claim has been received by
the corporation, the claimant may at any time thereafter bring suit against
the corporation to recover the unpaid amount of the claim and, if successful
in whole or in part, the claimant shall be entitled to be paid also the expense
of prosecuting such claim. It shall be a defense of any such action (other than
an action brought to enforce a claim for expenses incurred in defending any
proceeding in advance of its final disposition where the required undertaking,
if any is required, has been tendered to the corporation) that the claimant has
not met the standards of conduct which makes it permissible under the Delaware
General Corporation Law for the corporation to indemnify the claimant for the
amount claimed but the burden of proving such defense shall be on the
corporation. Neither the failure of the corporation (including its board of
directors, independent legal counsel, or its stockholders) to have made a
determination prior to the commencement of such action that indemnification of
the claimant is proper in the circumstances because he or she has met the
applicable standard of conduct set forth in the Delaware General Corporation
Law, nor an actual determination by the corporation (including its board of
directors, independent legal counsel, or its stockholders) that the claimant has
not met such applicable standard of conduct, shall be a defense to the action or
create a presumption that the claimant has not met the applicable standard of
conduct.
(iii) The right to indemnification and the payment of expenses incurred in
defending a proceeding in advance of its final disposition shall not be
exclusive of any other right which any person may have or hereafter acquire
under any statute, provision of the Certificate of Incorporation, By-laws,
agreement, vote of stockholders or disinterested directors or otherwise.
In addition, we maintain a directors' and officers' liability insurance
policy.
ITEM 16. EXHIBITS
EXHIBIT NO. DESCRIPTION
5.1 Opinion of Robinson & Cole LLP
23.1 Consent of Independent Registered Public Accounting Firm
23.2 Consent of Robinson & Cole LLP (included in Exhibit 5.1)
24.1 Power of Attorney (included on the signature page hereof)
99.1 Accountant's Awareness Letter
ITEM 17. UNDERTAKINGS
The undersigned Registrant hereby undertakes:
1. To file, during any period in which offers or sales are being made,
a post-effective amendment to this Registration Statement:
(i) To include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933, as amended;
(ii) To reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a
fundamental change in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that
which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of prospectus
filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in
the aggregate, the changes in volume and price represent no more than 20 percent
change in the maximum aggregate offering price set forth in the "Calculation of
Registration Fee" table in the effective registration statement.
iii) To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement;
provided, however, that paragraphs 1(i) and (1)(ii) of this section do not
apply if the registration statement is on Form S-3, Form S-8 or Form F-3, and
the information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed with or furnished to the
Commission by the registrant pursuant to section 13 or section 15(d) of the
Securities Exchange Act of 1934 that are incorporated by reference in the
registration statement.
2. That, for the purpose of determining any liability under the
Securities Act of 1933, as amended, each such post-effective amendment shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
3. To remove from registration by means of a post-effective amendment any of
the securities being registered which remain unsold at the termination of the
offering.
4. That, for purposes of determining any liability under the Securities
Act of 1933, each filing of the registrant's annual report pursuant to section
13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where
applicable, each filing of an employee benefit plan's annual report pursuant to
section 15(d) of the Securities Exchange Act of 1934) that is incorporated by
reference in the registration statement shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering
thereof.
Insofar as indemnification for liabilities arising under the Securities Act
of 1933, as amended, may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise,
the registrant has been advised that in the opinion of the Securities and
Exchange Commission such indemnification is against public policy as expressed
in the Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act and will
be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this registration
statement on Form S-3 to be signed on its behalf by the undersigned, thereunto
duly authorized, in the Town of Hauppauge, State of New York, on December 21,
2005.
ORBIT INTERNATIONAL CORP.
By: /s/ Dennis Sunshine
-------------------
Dennis Sunshine
Chief Executive Officer and President
Each such person whose signature appears below hereby appoints Dennis
Sunshine and Bruce Reissman, and each of them, each of whom may act without
joinder of the other, as his or her true and lawful attorney-in-fact and agent,
with full power and substitution and resubstitution, for him or her and in his
or her name, place and stead, in any and all capacities, to execute in the name
and on behalf of such person any amendment or any post-effective amendment to
this Registration Statement, and any registration statement relating to any
offering made in connection with the offering covered by this Registration
Statement that is to be effective on filing pursuant to Rule 462(b) under the
Securities Act of 1933, as amended, and to file the same, with exhibits thereto,
and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact and agents full power and
authority to do and perform each and every act and thing appropriate or
necessary to be done, as full and for all intents and purposes and he or she
might or could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents or their substitute or substitutes may lawfully do
or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated.
SIGNATURE TITLE DATE
/s/ Dennis Sunshine Chairman of the Board, President December 21, 2005
- ------------------- Chief Executive Officer
Dennis Sunshine and Director
(Principal Executive Officer)
/s/ Bruce Reissman Executive Vice President, December 21,2005
- ------------------- Chief Operating Officer
Bruce Reissman and Director
/s/ Mitchell Binder Vice President - Finance, December 21,2005
- ------------------- Chief Financial Officer
Mitchell Binder (Principal Accounting
and Financial Officer)
and Director
Arthur Rhein Director
- -------------
Bernard Karcinell Director
- ------------------
Denis Feldman Director
- --------------
/s/ Lee Feinberg Director December 21, 2005
- ------------------
Lee Feinberg
INDEX OF EXHIBITS
EXHIBIT NO. DESCRIPTION
5.1 Opinion of Robinson & Cole LLP
23.1 Consent of Independent Registered Public Accounting Firm
23.2 Consent of Robinson & Cole LLP (included in Exhibit 5.1)
24.1 Power of Attorney (included on the signature page hereof)
99.1 Accountant's Awareness Letter